TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23803594

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Neostigmine 10 µg kg(‐1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Neostigmine 20 µg kg(‐1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Neostigmine 30 µg kg(‐1)
Number of subjects: 48
Study: 21814293

Group type: EXPERIMENTAL
Intervention: Strict blood pressure control (target systolic BP <140 mm Hg)
Number of subjects: 2865

Group type: COMPARATOR
Intervention: Mild blood pressure control (target systolic BP 140-159 mm Hg)
Number of subjects: 2865
Study: 19339405

Group type: EXPERIMENTAL
Intervention: Reduction in liquid calorie intake of 100 kcal/d
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Reduction in sugar-sweetened beverage (SSB) intake of 1 serving/d
Number of subjects: 810
Study: 21795297

Group type: EXPERIMENTAL
Intervention: Clopidogrel withdrawal
Number of subjects: 33
Study: 16330915

Group type: EXPERIMENTAL
Intervention: Clopidogrel in combination with aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination antiplatelet therapy with clopidogrel and aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibition
Number of subjects: 0
Study: 12186987

Group type: EXPERIMENTAL
Intervention: Highly purified FSH (Fostimon)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (Menogon)
Number of subjects: 153
Study: 9615851

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 18

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 18
Study: 7806018

Group type: EXPERIMENTAL
Intervention: Subjects with non-insulin-dependent diabetes mellitus
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Subjects with impaired glucose tolerance
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Area under the non-esterified fatty acid suppression curve
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Waist-hip ratio
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Fasting insulin concentration
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: 30-min insulin increment
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 1122
Study: 2642707

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 45
Study: 51576

Group type: EXPERIMENTAL
Intervention: Menaquinone therapy alone
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Menaquinone therapy with hyposensitization therapy
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 11595381

Group type: EXPERIMENTAL
Intervention: Ozone challenge in healthy subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ozone challenge in mild asthmatic subjects
Number of subjects: 0
Study: 31337037

Group type: EXPERIMENTAL
Intervention: Micro-grafts from Human Intra- and Extra-Dermal Adipose Tissue-Derived Hair Follicle Stem Cells (HD-AFSCs)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Micro-grafts from HD-AFSCs
Number of subjects: 33
Study: 30111240

Group type: EXPERIMENTAL
Intervention: Tenease therapy (mechanical high-frequency vibration device)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard treatment (physiotherapy, activity modification, and analgesia)
Number of subjects: 54
Study: 28065227

Group type: EXPERIMENTAL
Intervention: Brochure group
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 134
Study: 25388660

Group type: EXPERIMENTAL
Intervention: Intervention (Mobile Technology for Improved Family Planning)
Number of subjects: 0
Study: 22119614

Group type: EXPERIMENTAL
Intervention: Colour-coded HbA1c graphical record
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 19861956

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (HT) for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) for 12 weeks
Number of subjects: 46
Study: 17593012

Group type: EXPERIMENTAL
Intervention: Topical pranoprofen 0.1%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac sodium 0.1%
Number of subjects: 40
Study: 16333028

Group type: EXPERIMENTAL
Intervention: FEC14 (604 patients)
Number of subjects: 1214
Study: 11972097

Group type: EXPERIMENTAL
Intervention: Chronic red cell transfusion (exchange or simple transfusion with washed, reconstituted, or packed red blood cells)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Simple transfusion with packed red cells
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Exchange transfusions
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Total transfusion volume of more than 250 mL/kg
Number of subjects: 61
Study: 9504437

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 0100 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 0700 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 1300 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 1900 h
Number of subjects: 12
Study: 8699518

Group type: EXPERIMENTAL
Intervention: Threaded, hydroxylapatite-coated implant
Number of subjects: 720
Study: 2759322

Group type: EXPERIMENTAL
Intervention: Postpartum isometric exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 40
Study: 132695

Group type: EXPERIMENTAL
Intervention: Feprazone, 200 mg t.d.s.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Indomethacin, 25 mg t.d.s. rising to 50 mg t.d.s.
Number of subjects: 23
Study: 30939411

Group type: EXPERIMENTAL
Intervention: Behavioral counseling intervention (11 sessions over 6 months)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no behavioral counseling)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Behavioral counseling intervention
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study: 29187388

Group type: COMPARATOR
Intervention: Almond diet (ALD) - 42.5 g/d of almonds
Number of subjects: 48

Group type: COMPARATOR
Intervention: Chocolate diet (CHOC) - 18 g/d of cocoa powder and 43 g/d of dark chocolate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Combined diet (CHOC+ALD) - all 3 foods (almonds, dark chocolate, cocoa)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Average American diet (control)
Number of subjects: 48
Study: 25194428

Group type: EXPERIMENTAL
Intervention: Chamomile tea (3 g/150 mL hot water) three times per day immediately after meals for 8 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Water regimen for 8 weeks
Number of subjects: 64
Study: 22402823

Group type: EXPERIMENTAL
Intervention: Educoeur
Number of subjects: 185

Group type: COMPARATOR
Intervention: Specialized clinic
Number of subjects: 185

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 185
Study: 21984399

Group type: EXPERIMENTAL
Intervention: Astaxanthin (AST) 4 mg/d for 28 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study: 19390720

Group type: EXPERIMENTAL
Intervention: Tracheostomy with isthmectomy (11 by general surgery team, 11 by thoracic surgery team)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Tracheostomy without isthmectomy
Number of subjects: 164
Study: 16505653

Group type: EXPERIMENTAL
Intervention: Automatic tube compensation (ATC) with continuous positive airway pressure (CPAP) during a spontaneous breathing trial (n=51)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) alone during a spontaneous breathing trial (n=48)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Automatic tube compensation (ATC) with CPAP
Number of subjects: 99

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) alone
Number of subjects: 99
Study: 12754584

Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition (Group II)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bolus enteral nutrition (Group I)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (Group I and Group II)
Number of subjects: 28
Study: 11119744

Group type: EXPERIMENTAL
Intervention: PCOS women
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy control women
Number of subjects: 27
Study: 8796411

Group type: EXPERIMENTAL
Intervention: Cardiac surgery with cardiopulmonary bypass
Number of subjects: 13
Study: 1636574

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (1.5 million units/60 minutes)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Intravenous anistreplase (30 units/2 to 5 minutes)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase or anistreplase
Number of subjects: 333
Study: 6434084

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 200
Study: 31914443

Group type: EXPERIMENTAL
Intervention: Allergen immunotherapy (AIT) plus pharmacological treatment
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 250
Study: 30507881

Group type: EXPERIMENTAL
Intervention: Acupoint application (plasters applied to designated points such as Tianzhu, Lianquan, Dazhui) before operation
Number of subjects: 880

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 880
Study: 29369985

Group type: EXPERIMENTAL
Intervention: External levator advancement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Müller muscle-conjunctival resection
Number of subjects: 40
Study: 26605807

Group type: COMPARATOR
Intervention: 1-minute rest intervals (SHORT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 3-minute rest intervals (LONG)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 21
Study: 24595228

Group type: EXPERIMENTAL
Intervention: Intramyocardial sevoflurane delivery
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Systemic sevoflurane delivery
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no sevoflurane)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sevoflurane treatment (both intramyocardial and systemic)
Number of subjects: 26
Study: 23318240

Group type: EXPERIMENTAL
Intervention: Community mobilization and household level waste management intervention
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1600
Study: 19939196

Group type: EXPERIMENTAL
Intervention: 5 mg oral folic acid supplement
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no folic acid)
Number of subjects: 26
Study: 17345047

Group type: EXPERIMENTAL
Intervention: Median Nerve Stimulation (MNS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control Stimulation (CS)
Number of subjects: 11
Study: 16262545

Group type: EXPERIMENTAL
Intervention: Bupropion with brief motivational counseling
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 600
Study: 12141578

Group type: EXPERIMENTAL
Intervention: COOP Charts with illustrations
Number of subjects: 6007

Group type: COMPARATOR
Intervention: COOP Charts without illustrations
Number of subjects: 6007
Study: 10683816

Group type: EXPERIMENTAL
Intervention: DHA (1.5 g DHA per day for 9 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (10 capsules of mixed plant oil per day for 9 weeks)
Number of subjects: 14
Study: 8944094

Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1836824

Group type: EXPERIMENTAL
Intervention: Group I (n = 15): respiration adjusted to maintain constant end-tidal CO2
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group II (n = 15): minute ventilation kept constant to monitor end-tidal CO2 changes
Number of subjects: 30
Study: 6130079

Group type: EXPERIMENTAL
Intervention: Buspirone (10 mg t.i.d.)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg t.i.d.)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 30511951

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training plus home exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Home exercise only
Number of subjects: 40
Study: 28319001

Group type: EXPERIMENTAL
Intervention: Weight Watchers (WW) approach supplemented with phone and email counseling with a certified diabetes educator (CDE)
Number of subjects: 563

Group type: COMPARATOR
Intervention: Standard Care (SC) - brief standard diabetes nutrition counseling and education
Number of subjects: 563
Study: 26120988

Group type: EXPERIMENTAL
Intervention: Vasonit and standard treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 45
Study: 22773619

Group type: EXPERIMENTAL
Intervention: Comics for Health program
Number of subjects: 0
Study: 20530296

Group type: EXPERIMENTAL
Intervention: C-reactive protein (baseline)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Pulse pressure (baseline)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Glucose (baseline)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Waist circumference (baseline)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Fibrinogen (baseline)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: C-reactive protein (cumulative exposure)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Current levels of augmentation index
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Pulse pressure heart rate product (20 years)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Established cardiovascular risk factors
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Inflammation and repetitive cyclic stress
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Acute inflammation
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Control of pulse pressure and heart rate, reducing inflammation
Number of subjects: 825
Study: 18411833

Group type: EXPERIMENTAL
Intervention: Asthma psychoeducation program with family therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Active group (intervention)
Number of subjects: 46
Study: 17067250

Group type: EXPERIMENTAL
Intervention: HoMBReS: Hombres Manteniendo Bienestar y Relaciones Saludables intervention
Number of subjects: 0
Study: 15599116

Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 28
Study: 10714568

Group type: EXPERIMENTAL
Intervention: Induction therapy consisting of stavudine + lamivudine + nelfinavir + saquinavir for 26 weeks
Number of subjects: 65
Study: 9172053

Group type: EXPERIMENTAL
Intervention: Aerobic dance for 20 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest for 20 minutes
Number of subjects: 10
Study: 8482307

Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 200

Group type: COMPARATOR
Intervention: metronidazole/gentamicin
Number of subjects: 200
Study: 3982268

Group type: EXPERIMENTAL
Intervention: PRE‐EX (N = 16) - Progressive walking program (4 days/week for 9 weeks) at 80% HRM
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: POST‐EX (N = 14) - Progressive walking program (4 days/week for 9 weeks) at 80% HRM
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 38
Study: 2836204

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol 200 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Atenolol 100 mg
Number of subjects: 8
Study: 29117643

Group type: EXPERIMENTAL
Intervention: Coated activated charcoal haemoperfusion (CAC‐HP) plus standard care (oral activated charcoal)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care (oral activated charcoal)
Number of subjects: 14
Study: 26335917

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 62

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 62
Study: 24318788

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (20‐min warm‐up program performed twice weekly for 10 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Neuromuscular training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 23322920

Group type: EXPERIMENTAL
Intervention: High job demands
Number of subjects: 12550

Group type: EXPERIMENTAL
Intervention: Low job control
Number of subjects: 12550

Group type: EXPERIMENTAL
Intervention: Prolonged standing
Number of subjects: 12550

Group type: EXPERIMENTAL
Intervention: Awkward lifting
Number of subjects: 12550

Group type: EXPERIMENTAL
Intervention: Squatting/kneeling
Number of subjects: 12550
Study: 21432597

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: If-then plans
Number of subjects: 0
Study: 18438059

Group type: EXPERIMENTAL
Intervention: Uterine artery embolisation
Number of subjects: 2

Group type: COMPARATOR
Intervention: Surgery (hysterectomy or myomectomy)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Uterine artery embolisation and Surgery
Number of subjects: 2
Study: 16893278

Group type: EXPERIMENTAL
Intervention: Therapeutic Workplace (n=22)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care control (n=25)
Number of subjects: 47
Study: 15328673

Group type: EXPERIMENTAL
Intervention: Fexofenadine hydrochloride (20, 60, 120, or 240 mg twice daily)
Number of subjects: 857

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 857
Study: 11247146

Group type: EXPERIMENTAL
Intervention: Turpentine white emulsion baths
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium chloride baths
Number of subjects: 100
Study: 9591449

Group type: EXPERIMENTAL
Intervention: Corticosteroids treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Post myocardial infarction syndrome (PMIS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pericardial effusion
Number of subjects: 22
Study: 8401048

Group type: EXPERIMENTAL
Intervention: Terbinafine 1% cream applied twice daily for one week
Number of subjects: 256

Group type: COMPARATOR
Intervention: Clotrimazole 1% cream applied twice daily for four weeks
Number of subjects: 256
Study: 3780287

Group type: EXPERIMENTAL
Intervention: Prophylactic salbutamol (200 micrograms 4-times daily)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Symptomatic placebo inhaler (2 actuations 4-times daily)
Number of subjects: 17
Study: 31869402

Group type: EXPERIMENTAL
Intervention: Second language (L2) training for 8 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (HCs)
Number of subjects: 11
Study: 29901486

Group type: EXPERIMENTAL
Intervention: Weight loss program with mindfulness training (n = 100)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Weight loss program without mindfulness training (n = 94)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Weight loss program with or without mindfulness training
Number of subjects: 194
Study: 26637959

Group type: EXPERIMENTAL
Intervention: Anti-obesity messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-obesity-related health messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral control task (word search)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sun exposure condition
Number of subjects: 0
Study: 24481711

Group type: EXPERIMENTAL
Intervention: Behavioral support of physical activity coupled with nutrition education
Number of subjects: 144

Group type: COMPARATOR
Intervention: Cognitive-behavioral methods for nutrition change
Number of subjects: 144
Study: 23059810

Group type: EXPERIMENTAL
Intervention: anti-TNF-α mAb+methotrexate for 24 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: placebo+methotrexate for the first 12 weeks and anti-TNF-α mAb+methotrexate for another 12 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: anti-TNF-α mAb+methotrexate
Number of subjects: 33
Study: 19875685

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg oral for 7 days)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 7 days)
Number of subjects: 265
Study: 18272040

Group type: EXPERIMENTAL
Intervention: Wavefront-guided LASIK (wg LASIK)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional LASIK
Number of subjects: 211
Study: 16032411

Group type: EXPERIMENTAL
Intervention: Alcohol (0.6 g/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 12590148

Group type: EXPERIMENTAL
Intervention: Bivariate DNA/cytokeratin analysis
Number of subjects: 157

Group type: COMPARATOR
Intervention: Univariate DNA analysis
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Cytokeratin-gated histograms
Number of subjects: 157
Study: 11089515

Group type: COMPARATOR
Intervention: 40 mg rizatriptan
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 mg rizatriptan
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg rizatriptan
Number of subjects: 0
Study: 9358715

Group type: EXPERIMENTAL
Intervention: Vanderbilt University Medical Center program (more intensive)
Number of subjects: 512

Group type: COMPARATOR
Intervention: American Cancer Society program (less intensive)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Both programs with nicotine-replacement therapy
Number of subjects: 512
Study: 8252888

Group type: EXPERIMENTAL
Intervention: Ranitidine 6.25 mg/hr continuous infusion
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 167
Study: 2939542

Group type: EXPERIMENTAL
Intervention: Nucleolysis with chymopapain (4,000 U of discase)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (discography followed by injection of distilled water)
Number of subjects: 39